Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 1989 | 2019 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.040 | None | 0.750 | 1 | 0 | 1996 | 2008 | ||||||||
|
BAF chromatin remodeling complex subunit BCL11B | 0.568 | 0.731 | 0.99 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
SKI proto-oncogene | 0.503 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
S-phase kinase associated protein 2 | 0.492 | 0.808 | 0.96 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
tripartite motif containing 24 | 0.581 | 0.615 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
TNF receptor superfamily member 10a | 0.521 | 0.731 | 5.1E-15 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2005 | 2018 | ||||||||
|
TNF receptor superfamily member 10b | 0.505 | 0.769 | 2.0E-04 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2007 | ||||||||
|
TNF receptor superfamily member 10c | 0.578 | 0.731 | 3.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
TNF receptor superfamily member 10d | 0.626 | 0.615 | 3.0E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
TNF superfamily member 13 | 0.499 | 0.769 | 0.82 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
Cbl proto-oncogene B | 0.691 | 0.423 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CBFA2/RUNX1 partner transcriptional co-repressor 3 | 0.638 | 0.462 | 4.8E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
C-type lectin domain family 12 member A | 0.686 | 0.346 | 2.6E-07 |
|
disease | 0.100 | None | 0.950 | 1 | 0 | 2004 | 2019 | ||||||||
|
neuropilin 1 | 0.476 | 0.808 | 0.99 |
|
disease | 0.160 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
CASP8 and FADD like apoptosis regulator | 0.485 | 0.846 | 1.00 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2005 | 2013 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2015 | ||||||||
|
GRB2 associated binding protein 2 | 0.563 | 0.692 | 0.98 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2006 | 2008 | ||||||||
|
CD79a molecule | 0.536 | 0.731 | 0.69 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1991 | 2019 | ||||||||
|
CD33 molecule | 0.524 | 0.769 | 5.7E-07 |
|
disease | 0.400 | None | 0.958 | 1 | 0 | 1991 | 2020 | ||||||||
|
CD86 molecule | 0.483 | 0.769 | 0.95 |
|
disease | 0.090 | None | 1.000 | 1 | 0 | 1998 | 2016 |